Search News
| 117.32 BATS BZX Real-Time Price As of 12:40pm ET |  +1.23 / +1.06%Today’s Change | 100.22 Today|||52-Week Range 120.06 | +9.88% Year-to-Date |
The investment seeks to track the investment results of the NASDAQ Biotechnology Index- which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq- Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures- options and swap contracts- cash and cash equivalents. It is non-diversified.
| Health Care ETFs Outperforming: Will the Rally Last? Aug 13 / Zacks.com - Paid Partner Content | Biotech ETFs in Focus on String of Q2 Earnings Beat Aug 10 / Zacks.com - Paid Partner Content |
| 1 month | -1.87% | 3 years | -0.06% | |
| 3 months | +7.79% | 5 years | +13.12% | |
| 1 year | +14.84% | Since inception | +7.53% |
| Previous close | $116.09 |
| Open day’s range | 116.26 – 117.35 |
| Net asset value (NAV) | 116.00 (08/20/2018) |
| Daily volume | 34,515 |
| Average volume (3 months) | 2,399,478 |
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +13.12% | +14.50% |
| Expense Gross exp ratio | 0.47% | 1.29% |
| Risk 5 year sharpe ratio | 0.62 | 0.91 |
| Net assets | $9.6B | $3.3B |
| Average market cap | $17.6B | $28.1B |
| Average P/E | 30.2 | 28.8 |
| Dividend / Share | -- | 0.31% |
| XLV Health Care Select Sector SPDR® Fund |
| FHLC Fidelity MSCI Health Care Index ETF |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
| GILD Gilead Sciences | 8.63% |
| BIIB Biogen | 8.50% |
| AMGN Amgen | 8.18% |
| CELG Celgene | 7.91% |
| ILMN Illumina Inc | 5.78% |
| REGN Regeneron Pharmaceuticals | 4.58% |
| VRTX Vertex Pharmaceuticals Inc | 4.25% |
| ALXN Alexion Pharmaceuticals Inc | 3.67% |
| MYL Mylan NV | 2.38% |
| BMRN Biomarin Pharmaceutical Inc | 2.20% |
